Case Reports in Pathology

Case Reports in Pathology / 2012 / Article

Case Report | Open Access

Volume 2012 |Article ID 353215 |

Gururajaparasad Chennakeshaviah, Sunila Ravishankar, Rangaswamy Maggad, G. V. Manjunath, "Solitary Giant Intramuscular Myxoid Neurofibroma Resulting in an above Elbow Amputation", Case Reports in Pathology, vol. 2012, Article ID 353215, 3 pages, 2012.

Solitary Giant Intramuscular Myxoid Neurofibroma Resulting in an above Elbow Amputation

Academic Editor: T. Ishikawa
Received19 Jul 2012
Accepted10 Oct 2012
Published03 Nov 2012


Neurofibromas are uncommon benign tumours and are still rarer in intramuscular locations. They are not detected until they cause a significant damage to the neighbouring tissues. We present a case of a giant intramuscular myxoid neurofibroma of the left forearm which eroded the radius and ulna, restricting the movements at the elbow and wrist joints and causing wrist drop resulting in an above elbow amputation. It was diagnosed by histopathology and was later confirmed by immunohistochemistry.

1. Introduction

Neurofibromas are tumours of the nerve sheath origin and may arise from the Schwann cells, perineural cells, and fibroblasts. Intramuscular neurofibromas are rare [1] and not detected till they cause a significant damage to the neighbouring tissues. We present a case of a giant intramuscular myxoid neurofibroma of the left arm which caused restricted movements of the elbow and wrist joints, erosion of the radius and ulna (Figure 1) and, wristdrop.

We present this case because being benign in nature, due to its giant size and location, this tumour caused complications like wristdrop, erosion of the bones and resulted in an above the elbow amputation.

2. Case Presentation

Here we present a case of 70 yrs male who presented with a painless swelling of the left forearm for the past one year, which incapacitated the movements at the elbow and wrist joints and resulted in wrist drop.

On clinical examination, the tumour was deep seated and the X-ray showed erosion of the radius and ulna. A clinical diagnosis of a malignant soft tissue tumour was made.

The patient was thoroughly examined for the clinical manifestations of neurofibromatosis. There were no “cafe au lait” spots, two or more neurofibromas, Lisch nodules, axillary or inguinal freckling, sphenoid wing dysplasia or thinning of the cortex of long bone, and optic glioma. At least two or more lesions are required for the diagnosis of neurofibroma [1].

An above elbow-amputated specimen of the left upper limb was received. The dissection showed a glistening white tumour located within the forearm muscles measuring 13.5 × 10.5 cms in association with the median nerve. Cut section was ivory white and glistening with myxoid areas.

3. Histopathology: (See Figures 2 and 3)

Histopathological examination showed a tumour with the cells arranged in lobules of anastamosing cords, strands, and nests against a background of myxoid material and intervening fibrous septae. The cells were spindle to elongated with scanty cytoplasm and showed elongated wavy nuclei. No mitoses were seen. Areas of haemorrhage were noted. A diagnosis of myxoid neurofibroma was made.

Immunohistochemistry showed expression of S100P by the tumour cells.

4. Discussion

Neurofibromas (NF) are rare tumours [1] and are further rare in intramuscular locations. All the cases are not associated with neurofibromatosis (NF1). The diffuse and the plexiform patterns have a close relation with neurofibromatosis. The solitary (sporadic) form occurs in those who do not have neurofibromatosis [1]. Myxoid neurofibromas are rarer than the typical ones. These tumours are confused often clinically and histopathologically with myxomas. Myxomas have no nerve involvement and are S100 negative [2].

The other differential diagnoses are the following.(i)Aggressive angiomyxoma are perineal or pelvic in location, shows prominent medium to large vessels.(ii)Low-grade fibromyxoid sarcoma shows alternating fibrous myxoid patterns with swirling and whorled appearance.(iii)Myxoid liposarcoma shows arborising vascular pattern, signet ring type of lipoblasts, and are more cellular.(iv)Nodular fasciitis moderately cellular with undulating bundles of cells, tissue culture appearance with tears, and spaces in the tissue.(v)Synovial sarcoma with monophasic or biphasic type and myxoid areas.(vi)Cellular myxoma showing moderate cellularity (20%), arching blood vessels, and collagenous stroma.(vii)Chordoma which shows physaliphorous cells.(viii) Schwannoma shows spindle cells with Antony A and Antony B areas.Histochemical and immunohistochemical stains are useful in the final diagnosis [1].

Myxoid neurofibroma (MN) is a benign tumour of perineural origin, which is demonstrated by a positive immunohistochemical staining for S100 protein. The most common locations are the face, shoulder, anus, periungal, and in the feet. Only one case occurring in the trunk is reported [2].

The presence of mitotic activity in neurofibroma is indicative of malignancy and is seen even in schwannoma [3].

One case each of a giant genitourinary plexiform neurofibroma associated with lower limb gigantism [4], periungal myxoid neurofibroma [5] in the large bowel [6], a solitary retroperitoneal neurofibroma without any stigmata of Von Recklinghausen’s disease [7], in the male breast [8], in the female breast [9], and a case of sacral neurofibroma [10] are reported. This case is being presented because of its rare location, a giant size, erosion of bones ulna and radius which incapacitated the movements at the elbow and wrist joints, resulting in wrist drop and had to end up in an “above elbow amputation”.


  1. S. W. Weiss and J. R. Goldblum, Enzinger and Weiss, Soft Tissue Tumours, Mosby-Harcourt Health Sciences Company, St. Louis, Mo, USA, 4th edition.
  2. R. Ponce-Olivera, A. Tirado-Sanchez, A. Peniche-Castellanos, J. Peniche-Rosado, and P. Mercadillo-Perez, “Myxoid neurofibroma: an unusual presentation,” Indian Journal of Dermatology, vol. 53, no. 1, pp. 35–36, 2008. View at: Publisher Site | Google Scholar
  3. S. Roy, “Neurofibroma,” Archives of Dermatology, vol. 36, no. 10, pp. 1207–1209, 2000. View at: Google Scholar
  4. E. Rallis and D. Ragiadakou, “Giant plexiform neurofibroma in a patient with neurofibromatosis type I,” Dermatology Online Journal, vol. 15, no. 5, article 7, 2009. View at: Google Scholar
  5. R. F. Gmyrek, R. Beer, D. N. Silvers, R. Reiffel, and M. E. Grossman, “Periungual myxoid neurofibroma,” Cutis, vol. 69, no. 1, pp. 54–56, 2002. View at: Google Scholar
  6. V. Panteris, T. Vassilakaki, N. Vaitsis, I. Elemenoglou, I. Mylonakou, and D. G. Karamanolis, “Solitary colonic neurofibroma in a patient with transient segmental colitis: case report,” World Journal of Gastroenterology, vol. 11, no. 35, pp. 5573–5576, 2005. View at: Google Scholar
  7. J. Ishikawa, S. Kamidono, S. Maeda et al., “Solitary retroperitoneal neurofibroma: a case report,” Acta Urologica Japonica, vol. 35, no. 7, pp. 1157–1160, 1989. View at: Google Scholar
  8. Y. L. Hock and W. Mohamid, “Myxoid neurofibroma of the male breast: fine needle aspiration cytodiagnosis,” Cytopathology, vol. 6, no. 1, pp. 44–47, 1995. View at: Google Scholar
  9. G. Gokalp, B. Hakyemez, E. Kizilkaya, and A. Haholu, “Myxoid neurofibromas of the breast: mammographical, sonographical and MRI appearances,” British Journal of Radiology, vol. 80, no. 958, pp. e234–237, 2007. View at: Google Scholar
  10. D. P. Barboriak, S. M. Rivitz, and F. S. Chew, “Sacral neurofibroma,” American Journal of Roentgenology, vol. 159, no. 3, article 600, e600. View at: Google Scholar

Copyright © 2012 Gururajaparasad Chennakeshaviah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.